Amalgamated-Financial

Filing Details

13F-HR2022-03-31
Report Date
2022-03-31
Filing Date
2022-05-16
Total Holdings
3,002
Total Value
12592024
Accession Number
0001823608-22-000095
Form Type
13F-HR
Manager Name
Amalgamated-Financial
Data Enrichment
80% identified
2,403 identified599 unidentified

Holdings

3,002 positions • $12.6M total value
Manager:
Search and click to pin securities to the top
Page 99 of 151
Delek US Holdings, Inc.
Shares:7.9K
Value:$168.0K
% of Portfolio:1.3% ($168.0K/$12.6M)
86646P103
Shares:14.3K
Value:$167.0K
% of Portfolio:1.3% ($167.0K/$12.6M)
806882106
Shares:3.2K
Value:$167.0K
% of Portfolio:1.3% ($167.0K/$12.6M)
TRIMAS CORP
Shares:5.2K
Value:$167.0K
% of Portfolio:1.3% ($167.0K/$12.6M)
UNIVERSAL INSURANCE HOLDINGS, INC.
Shares:12.4K
Value:$167.0K
% of Portfolio:1.3% ($167.0K/$12.6M)
PAR TECHNOLOGY CORP
Shares:4.1K
Value:$167.0K
% of Portfolio:1.3% ($167.0K/$12.6M)
16383L106
Shares:6.7K
Value:$167.0K
% of Portfolio:1.3% ($167.0K/$12.6M)
GLADSTONE LAND Corp
Shares:4.6K
Value:$166.0K
% of Portfolio:1.3% ($166.0K/$12.6M)
OPKO HEALTH, INC.
Shares:48.2K
Value:$166.0K
% of Portfolio:1.3% ($166.0K/$12.6M)
Atlanta Braves Holdings, Inc.
Shares:5.9K
Value:$166.0K
% of Portfolio:1.3% ($166.0K/$12.6M)
FIBROGEN INC
Shares:13.7K
Value:$165.0K
% of Portfolio:1.3% ($165.0K/$12.6M)
829226109
Shares:5.8K
Value:$164.0K
% of Portfolio:1.3% ($164.0K/$12.6M)
Cytek Biosciences, Inc.
Shares:15.2K
Value:$164.0K
% of Portfolio:1.3% ($164.0K/$12.6M)
Bally's Corp
Shares:5.3K
Value:$164.0K
% of Portfolio:1.3% ($164.0K/$12.6M)
54911Q107
Shares:9.9K
Value:$164.0K
% of Portfolio:1.3% ($164.0K/$12.6M)
UMH PROPERTIES, INC.
Shares:6.7K
Value:$164.0K
% of Portfolio:1.3% ($164.0K/$12.6M)
Stock Yards Bancorp, Inc.
Shares:3.1K
Value:$164.0K
% of Portfolio:1.3% ($164.0K/$12.6M)
049904105
Shares:228
Value:$163.0K
% of Portfolio:1.3% ($163.0K/$12.6M)
Ladder Capital Corp
Shares:13.7K
Value:$163.0K
% of Portfolio:1.3% ($163.0K/$12.6M)
Krystal Biotech, Inc.
Shares:2.4K
Value:$162.0K
% of Portfolio:1.3% ($162.0K/$12.6M)